Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Cyclopenin is an acetylcholinesterase inhibitor produced by Penicillium, which demonstrates a significant selectivity for human recombinant acetylcholinesterase over equine butyrylcholinesterase. It also possesses antibacterial properties against E. coli and M. pyogenes.

20007-87-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (3R,3'S)-4-methyl-3'-phenyl-1H-spiro[1,4-benzodiazepine-3,2'-oxirane]-2,5-dione

    Cas No: 20007-87-8

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 20007-87-8 Structure
  • Basic information

    1. Product Name: cyclopenin
    2. Synonyms: cyclopenin
    3. CAS NO:20007-87-8
    4. Molecular Formula: C17H14N2O3
    5. Molecular Weight: 294.3047
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 20007-87-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 572.5°Cat760mmHg
    3. Flash Point: 300.1°C
    4. Appearance: /
    5. Density: 1.4g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: cyclopenin(CAS DataBase Reference)
    10. NIST Chemistry Reference: cyclopenin(20007-87-8)
    11. EPA Substance Registry System: cyclopenin(20007-87-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 20007-87-8(Hazardous Substances Data)

20007-87-8 Usage

Uses

Used in Pharmaceutical Applications:
Cyclopenin is used as an inhibitor for acetylcholinesterase (AChE) due to its high selectivity and potency, with an IC50 value of 2.04 μM for human recombinant AChE. This makes it a potential candidate for the treatment of conditions related to AChE dysregulation.
Used in Antibacterial Applications:
Cyclopenin is used as an antibacterial agent against E. coli and M. pyogenes, providing a potential therapeutic option for treating infections caused by these bacteria.
Used in Research and Development:
Cyclopenin's selectivity and activity against specific targets make it a valuable compound for research and development in the fields of neuroscience and microbiology, where understanding the mechanisms of AChE inhibition and bacterial growth inhibition can lead to the development of new therapeutic strategies.

Check Digit Verification of cas no

The CAS Registry Mumber 20007-87-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,0,0 and 7 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 20007-87:
(7*2)+(6*0)+(5*0)+(4*0)+(3*7)+(2*8)+(1*7)=58
58 % 10 = 8
So 20007-87-8 is a valid CAS Registry Number.

20007-87-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Cyclopenin

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20007-87-8 SDS

20007-87-8Relevant articles and documents

Harnessing the Substrate Promiscuity of Dioxygenase AsqJ and Developing Efficient Chemoenzymatic Synthesis for Quinolones

Tang, Haoyu,Tang, Yijie,Kurnikov, Igor V.,Liao, Hsuan-Jen,Chan, Nei-Li,Kurnikova, Maria G.,Guo, Yisong,Chang, Wei-Chen

, p. 7186 - 7192 (2021/06/30)

Nature has developed complexity-generating reactions within natural product biosynthetic pathways. However, direct utilization of these pathways to prepare compound libraries remains challenging because of limited substrate scopes, involvement of multiple-step reactions, and moderate robustness of these sophisticated enzymatic transformations. Synthetic chemistry offers an alternative approach to prepare natural product analogues. However, because of complex and diverse functional groups appended on the targeted molecules, dedicated design and development of synthetic strategies are typically required. Herein, by leveraging the power of chemoenzymatic synthesis, we report an approach to bridge the gap between biological and synthetic strategies in the preparation of quinolone alkaloid analogues. Leading byin silicoanalysis, the predicted substrate analogues were chemically synthesized. The AsqJ-catalyzed asymmetric epoxidation of these substrate analogues was followed by a Lewis acid-triggered ring contraction to complete the viridicatin formation. We evaluated the robustness of this method in gram-scale reactions. Lastly, through chemoenzymatic cascades, a library of quinolone alkaloids is effectively prepared.

Epoxidation Catalyzed by the Nonheme Iron(II)- A nd 2-Oxoglutarate-Dependent Oxygenase, AsqJ: Mechanistic Elucidation of Oxygen Atom Transfer by a Ferryl Intermediate

Cha, Lide,Chan, Nei-Li,Chang, Wei-Chen,Guo, Yisong,Huang, Jhih-Liang,Kurnikov, Igor V.,Kurnikova, Maria G.,Lee, Justin L.,Li, Jikun,Liao, Hsuan-Jen,Lin, Te-Sheng,Tang, Yijie

, p. 6268 - 6284 (2020/04/27)

Mechanisms of enzymatic epoxidation via oxygen atom transfer (OAT) to an olefin moiety is mainly derived from the studies on thiolate-heme containing epoxidases, such as cytochrome P450 epoxidases. The molecular basis of epoxidation catalyzed by nonheme-iron enzymes is much less explored. Herein, we present a detailed study on epoxidation catalyzed by the nonheme iron(II)- A nd 2-oxoglutarate-dependent (Fe/2OG) oxygenase, AsqJ. The native substrate and analogues with different para substituents ranging from electron-donating groups (e.g., methoxy) to electron-withdrawing groups (e.g., trifluoromethyl) were used to probe the mechanism. The results derived from transient-state enzyme kinetics, M?ssbauer spectroscopy, reaction product analysis, X-ray crystallography, density functional theory calculations, and molecular dynamic simulations collectively revealed the following mechanistic insights: (1) The rapid O2 addition to the AsqJ Fe(II) center occurs with the iron-bound 2OG adopting an online-binding mode in which the C1 carboxylate group of 2OG is trans to the proximal histidine (His134) of the 2-His-1-carboxylate facial triad, instead of assuming the offline-binding mode with the C1 carboxylate group trans to the distal histidine (His211); (2) The decay rate constant of the ferryl intermediate is not strongly affected by the nature of the para substituents of the substrate during the OAT step, a reactivity behavior that is drastically different from nonheme Fe(IV)-oxo synthetic model complexes; (3) The OAT step most likely proceeds through a stepwise process with the initial formation of a C(benzylic)-O bond to generate an Fe-alkoxide species, which is observed in the AsqJ crystal structure. The subsequent C3-O bond formation completes the epoxide installation.

Insights into the Desaturation of Cyclopeptin and its C3 Epimer Catalyzed by a non-Heme Iron Enzyme: Structural Characterization and Mechanism Elucidation

Liao, Hsuan-Jen,Li, Jikun,Huang, Jhih-Liang,Davidson, Madison,Kurnikov, Igor,Lin, Te-Sheng,Lee, Justin L.,Kurnikova, Maria,Guo, Yisong,Chan, Nei-Li,Chang, Wei-Chen

supporting information, p. 1831 - 1835 (2018/01/27)

AsqJ, an iron(II)- and 2-oxoglutarate-dependent enzyme found in viridicatin-type alkaloid biosynthetic pathways, catalyzes sequential desaturation and epoxidation to produce cyclopenins. Crystal structures of AsqJ bound to cyclopeptin and its C3 epimer ar

Mechanistic Investigation of a Non-Heme Iron Enzyme Catalyzed Epoxidation in (-)-4′-Methoxycyclopenin Biosynthesis

Chang, Wei-Chen,Li, Jikun,Lee, Justin L.,Cronican, Andrea A.,Guo, Yisong

supporting information, p. 10390 - 10393 (2016/09/04)

Mechanisms have been proposed for α-KG-dependent non-heme iron enzyme catalyzed oxygen atom insertion into an olefinic moiety in various natural products, but they have not been examined in detail. Using a combination of methods including transient kinetics, M?ssbauer spectroscopy, and mass spectrometry, we demonstrate that AsqJ-catalyzed (-)-4′-methoxycyclopenin formation uses a high-spin Fe(IV)-oxo intermediate to carry out epoxidation. Furthermore, product analysis on 16O/18O isotope incorporation from the reactions using the native substrate, 4′-methoxydehydrocyclopeptin, and a mechanistic probe, dehydrocyclopeptin, reveals evidence supporting oxo? hydroxo tautomerism of the Fe(IV)-oxo species in the non-heme iron enzyme catalysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20007-87-8